PD-L1 is also upregulated on tumor cells and tumor-associated myeloid cells, and impairs T-cell-induced immune responses upon engaging its cognate co-inhibitory receptor, programmed cell death 1 (PD-1), which is always highly expressed on tumor-infiltrating lymphocytes (TILs) [10]. The gene discussed is CD274; the disease is neoplasm.